Drug General Information
Drug ID
D0YA2L
Former ID
DAP000396
Drug Name
Teriparatide
Synonyms
Forteo; Forteo (TN); Teriparatide (genetical recombination); Teriparatide (USAN/INN); Teriparatide (genetical recombination) (JAN)
Drug Type
Small molecular drug
Indication Osteogenesis imperfecta [ICD9: 756.51; ICD10:Q78.0] Approved [467716], [536361]
Unspecified Investigative [1572605]
Therapeutic Class
Bone Density Conservation Agents
Company
Eli Lilly
Structure
Download
2D MOL

3D MOL

Formula
C181H291N55O51S2
CAS Number
CAS 52232-67-4
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
H05AA02
SuperDrug CAS ID
cas=052232674
Target and Pathway
Target(s) Parathyroid hormone ligand Target Info Modulator [556264]
Reactome Class B/2 (Secretin family receptors)
G alpha (s) signalling events
WikiPathways Endochondral Ossification
Osteoblast Signaling
Vitamin D Receptor Pathway
GPCR ligand binding
GPCR downstream signaling
Vitamin D Metabolism
References
Ref 467716(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4448).
Ref 536361Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20.
Ref 1572605The ChEMBL database in 2017.
Ref 556264Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.